SBF takes medication for depression every day while in prison and plans to launch a new token after his release
Svmuu News: FTX founder Sam Bankman-Fried is currently serving his sentence at Lompoc Federal Prison in California, where he takes Adderall and Emsam daily to treat clinical depression and attention-deficit/hyperactivity disorder (ADHD). While in prison, SBF continues to write a serialized memoir titled *Manfred*, which he sends to a select few friends and family members via the prison mail system. As a committed vegetarian, SBF does not eat in the prison cafeteria; instead, he purchases ingredients from the prison store to prepare his own meals and has compiled a “vegetarian prison cookbook.” SBF spent approximately $135 to purchase a prison-issued tablet and has played the same game about 6,000 times. (New York Magazine)
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Aethir (ATH) Token Value Analysis: Decentralized Cloud Computing Project Potential and Risk Assessment
-
2
What is WKAI? Wrapped KardiaChain (WKAI) Project Analysis and Risk Warning
-
3
HYN (Hyperion) Analysis: Decentralized Map Project Status and Market Activity Review
-
4
Bitcoin rises above $77,000, bucking tech selloff driven by AI safety concerns and rising oil prices
-
5
NOAH Coin Analysis: Distinguishing Between Controversial Projects and Active Payment Infrastructure
-
6
RIKEN Coin Value Analysis: Numerous Projects Share the Same Name, What's Its Investment Potential?
-
7
FXBK Coin Analysis: What Is It? Is It Worth Investing In?
-
8
Guyana's President: Oil Revenue Surges Due to Iran Conflict
-
9
Cosco Shipping Heavy Industry Completes China IPO Guidance Registration
-
10
Beginner's Guide to Bitcoin Trading: A Comprehensive Analysis of Security Risks and Prevention Strategies
Markets Today
Recommended Reading









